MedTrace Logo

Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes

NCT00108303 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 538

Last updated 2016-01-07

Study results available
· View outcomes & findings →

Summary

Schizophrenia has long been known to be an illness with significant evidence for a genetic predisposition. The purpose of this study is to determine the genetic abnormalities that cause childhood and adult onset schizophrenia.

Conditions

Interventions

OTHER

Diagnostic

Diagnostic evaluation for schizophrenia. Schizophrenia includes schizophrenia and schizoaffective disorder.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Robert Freedman, MD · VA Eastern Colorado Health Care System, Denver

Eligibility

Min Age
1 Year
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00108303 on ClinicalTrials.gov